Real Chemistry Unveils Suite of AI Tools for Healthcare Commercialization
The Anatomi ecosystem combines agentic and analytics tools.
A new ecosystem of tech tools from Real Chemistry is aimed at offering health and pharma marketers artificial intelligence support throughout the entire commercialization process.
The set of solutions, collectively known as Anatomi and launched Tuesday, include analytics and agentic AI tools built on large language models and orchestration platforms and drawing from a combination of proprietary and third-party data, all of which is gathered and stored “in a highly controlled and compliant way,” per the agency’s announcement.
The Anatomi suite’s offerings span the marketing, medical affairs, communications and media sectors. Specific tools include AI-powered solutions to aid in market trend analysis, brand strategy development, content creation, compliance risk evaluation, scientific publications planning and execution, and more.
Anatomi is also home to the latest iteration of HealthGEO, the AI search intelligence platform that Real Chemistry debuted last summer.
The ecosystem represents the agency’s efforts to embed AI and other digital tools in its workflows from the ground up, rather than “simply applying AI to existing ways of working,” Andy Johnson, Real Chemistry’s chief information officer, said in the release.
“Like human anatomy, Real Chemistry ANATOMI is designed as a connected, evolving system that will continue to advance alongside technological advances and clients’ changing needs—enabling faster decision-making, higher-quality execution and more connected ways of working to deliver meaningful, measurable outcomes for our clients and the providers and patients they serve,” Johnson said.
Anatomi arrives the same day as another AI-powered commercialization suite: Doceree also chose Tuesday to officially launch its Daily Command platform, billed by the martech maker as a unified, AI-powered operating system for managing the planning, execution and measurement of health and pharma marketing work.
solli’s Final Thoughts
AI’s applications in pharma media and marketing are rapidly advancing, and agencies, brands and tech developers are racing to keep up with the resulting industrywide paradigm shifts.
Not only can AI tools accelerate the entire marketing lifecycle and take on tedious tasks around data analysis and regulatory compliance but, in doing so, they can also free up human staffers to dig into more complex work.
As discussed in a recent solli feature about agentic AI’s impact on pharma media agencies, perhaps most successful in the age of AI will be those that move quickly to embed high-tech solutions into nearly every facet of the workflow, training automated agents to work independently and cross-functionally while still keeping human experts in the loop for oversight.
